Overview
Background
Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)
- Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
- Clinician Research Fellow, Metro North Hospital and Health Service
- Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research
Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.
Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.
Availability
- Dr Matthew Roberts is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biomedical Science, The University of Queensland
- Bachelor of Medicine, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Research interests
-
Urology
All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.
Works
Search Professor Matthew Roberts’s works on UQ eSpace
2022
Conference Publication
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC)
Pathmanathan, Shivanshan, Tariq, Arsalan, Gan, Chun Loo, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Philip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C. and Roberts, Matthew (2022). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, 3-7 June 2022. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2022.40.16_suppl.4540
2022
Journal Article
All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others
Emmett, Louise, Pattison, David A. and Roberts, Matthew J. (2022). All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others. European urology oncology, 5 (3), 283-284. doi: 10.1016/j.euo.2022.04.002
2022
Journal Article
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)
Tariq, Arsalan, McGeorge, Stephen, Pearce, Adam, Rhee, Handoo, Wood, Simon, Kyle, Samuel, Marsh, Philip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT). Urologic Oncology: Seminars and Original Investigations, 40 (6), 276.e1-276.e9. doi: 10.1016/j.urolonc.2022.03.007
2022
Journal Article
Guideline of guidelines: management of recurrent urinary tract infections in women
Kwok, Michael, McGeorge, Stephen, Mayer‐Coverdale, Johanna, Graves, Bianca, Paterson, David L., Harris, Patrick N.A., Esler, Rachel, Dowling, Caroline, Britton, Sumudu and Roberts, Matthew J. (2022). Guideline of guidelines: management of recurrent urinary tract infections in women. BJU International, 11 (2), 104-107. doi: 10.1111/bju.15756
2022
Journal Article
Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis
Ezure, Yukiko, Rico, Veronica, Paterson, David L., Hall, Lisa, Harris, Patrick N. A., Soriano, Alex, Roberts, Jason A., Bassetti, Matteo, Roberts, Matthew J., Righi, Elda and Wright, Hugh (2022). Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis. Open Forum Infectious Diseases, 9 (5) ofaa480, ofaa480. doi: 10.1093/ofid/ofaa480
2022
Journal Article
Painless penile periurethral polymicrobial abscess causing urinary retention
Tariq, Arsalan, Stewart, Adam G., Teloken, Patrick E., Dunglison, Nigel T., Martin, Benjamin F. and Roberts, Matthew J. (2022). Painless penile periurethral polymicrobial abscess causing urinary retention. Urology Case Reports, 42 102037, 1-3. doi: 10.1016/j.eucr.2022.102037
2022
Journal Article
The continuing impacts of the COVID-19 pandemic on diagnosis and surgical prostate cancer management: a population-based analysis
Papa, Nathan, Roberts, Matthew J. and Perera, Marlon (2022). The continuing impacts of the COVID-19 pandemic on diagnosis and surgical prostate cancer management: a population-based analysis. ANZ Journal of Surgery, 92 (5) 17646, 950-952. doi: 10.1111/ans.17646
2022
Journal Article
Pituitary metastasis of renal cell carcinoma characterized by 18F-prostate-specific membrane antigen-1007 PET/CT
Tariq, Arsalan, Raman, Vignesh, Alexander, Hamish, Roberts, Matthew J. and Thomas, Paul (2022). Pituitary metastasis of renal cell carcinoma characterized by 18F-prostate-specific membrane antigen-1007 PET/CT. Clinical Nuclear Medicine, 47 (4), E346-E347. doi: 10.1097/RLU.0000000000004055
2022
Journal Article
High PSMA PET SUVmax in PI‐RADS 4 or 5 men confers a high probability of significant prostate cancer
Ptasznik, Gideon, Papa, Nathan, Kelly, Brian D., Thompson, James, Stricker, Phillip, Roberts, Matthew J., Hofman, Michael, Buteau, James, Murphy, Declan G., Emmett, Louise and Moon, Daniel (2022). High PSMA PET SUVmax in PI‐RADS 4 or 5 men confers a high probability of significant prostate cancer. BJU International, 130 (S3), 5-7. doi: 10.1111/bju.15736
2022
Journal Article
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise and Yaxley, John W. (2022). Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 49 (9), 3289-3294. doi: 10.1007/s00259-022-05756-2
2022
Journal Article
Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer
Raveenthiran, S., Yaxley, W. J., Franklin, T., Coughlin, G., Roberts, M., Gianduzzo, T., Kua, B., Samaratunga, H., Delahunt, B., Egevad, L., Wong, D., McEwan, L., Brown, N., Parkinson, R., Esler, R. and Yaxley, J. W. (2022). Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer. Journal of Urology, 207 (3), 573-580. doi: 10.1097/JU.0000000000002293
2022
Journal Article
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison
Tariq, Arsalan, Kwok, Michael, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Marsh, Phillip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison. Urologic Oncology: Seminars and Original Investigations, 40 (2) 66.e1, 66.e1-66.e9. doi: 10.1016/j.urolonc.2021.11.006
2022
Journal Article
EDITORIAL COMMENT
Roberts, Matthew J. and Emmett, Louise (2022). EDITORIAL COMMENT. Journal of Urology, 207 (2), 348-349. doi: 10.1097/JU.0000000000002254.01
2022
Journal Article
Optimizing combined Magnetic Resonance Imaging (MRI)-targeted and systematic biopsy strategies: sparing the multiparametric MRI-negative transitional zone in presence of exclusively peripheral multiparametric MRI-suspect lesions
Kachanov, Mykyta, Leyh-Bannurah, Sami-Ramzi, Roberts, Matthew J., Sauer, Markus, Beyersdorff, Dirk, Boiko, Svitlana, Maurer, Tobias, Steuber, Thomas, Graefen, Markus and Budaus, Lars (2022). Optimizing combined Magnetic Resonance Imaging (MRI)-targeted and systematic biopsy strategies: sparing the multiparametric MRI-negative transitional zone in presence of exclusively peripheral multiparametric MRI-suspect lesions. Journal of Urology, 207 (2), 333-340. doi: 10.1097/JU.0000000000002248
2022
Journal Article
Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
Arnfield, Evyn G., Roberts, Matthew J. and Pattison, David A. (2022). Lymph node classification in E-PSMA reporting guidelines for PSMA-PET. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 1-2. doi: 10.1007/s00259-022-05943-1
2022
Journal Article
Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis
Kwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John W. and Roberts, Matthew J. (2022). Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis. Journal of Clinical Urology, 17 (6), 205141582210998-587. doi: 10.1177/20514158221099856
2022
Journal Article
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study
Nepogodiev, Dmitri, Simoes, Joana FF, Li, Elizabeth, Picciochi, Maria, Glasbey, James C, Baiocchi, Glauco, Blanco-Colino, Ruth, Chaudhry, Daoud, AlAmeer, Ehab, El-Boghdadly, Kariem, Wuraola, Funmilola, Ghosh, Dhruva, Gujjuri, Rohan R, Harrison, Ewen M, Lule, Herman, Kaafarani, Haytham, Khosravi, Mohammad, Kronberger, Irmgard, Leventoglu, Sezai, Mann, Harvinder, Mclean, Kenneth A, Mengesha, Mengistu Gebreyohanes, Modolo, Maria Marta, Ntirenganya, Faustin, Norman, Lisa, Outani, Oumaima, Pius, Riinu, Pockney, Peter, Qureshi, Ahmad Uzair ... Mutambanengwe, Precious G T (2022). SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77 (1), 28-39. doi: 10.1111/anae.15563
2021
Journal Article
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
Chikatamarla, Venkata Avinash, Okano, Satomi, Jenvey, Peter, Ansaldo, Alexander, Roberts, Matthew J., Ramsay, Stuart C., Thomas, Paul A. and Pattison, David A. (2021). Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI Research, 11 (1) 128, 128. doi: 10.1186/s13550-021-00869-5
2021
Journal Article
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study
Emmett, Louise, Buteau, James, Papa, Nathan, Moon, Daniel, Thompson, James, Roberts, Matthew J., Rasiah, Kris, Pattison, David A., Yaxley, John, Thomas, Paul, Hutton, Anthony C., Agrawal, Shikha, Amin, Amer, Blazevski, Alexandar, Chalasani, Venu, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Sheehan-Dare, Gemma, Kooner, Raji, Coughlin, Geoff, Chan, Lyn, Cusick, Thomas, Namdarian, Benjamin, Kapoor, Jada, Alghazo, Omar, Woo, Henry H., Lawrentschuk, Nathan ... Stricker, Phillip (2021). The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. European Urology, 80 (6), 682-689. doi: 10.1016/j.eururo.2021.08.002
2021
Journal Article
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Glasbey, James, Ademuyiwa, Adesoji, Adisa, Adewale, Alameer, Ehab, Arnaud, Alexis P, Ayasra, Faris, Azevedo, José, Minaya-Bravo, Ana, Costas-Chavarri, Ainhoa, Edwards, John, Elhadi, Muhammed, Fiore, Marco, Fotopoulou, Christina, Gallo, Gaetano, Ghosh, Dhruva, Griffiths, Ewen A, Harrison, Ewen, Hutchinson, Peter, Lawani, Ismail, Lawday, Samuel, Lederhuber, Hans, Leventoglu, Sezai, Li, Elizabeth, Gomes, Gustavo Mendonça Ataíde, Mann, Harvinder, Marson, Ella J, Martin, Janet, Mazingi, Dennis, McLean, Kenneth ... Aldawbali, M. (2021). Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. The Lancet Oncology, 22 (11), 1507-1517. doi: 10.1016/S1470-2045(21)00493-9
Funding
Current funding
Supervision
Availability
- Dr Matthew Roberts is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices
Associate Advisor
Other advisors: Professor Kristofer Thurecht, Dr Nick Rukin
Media
Enquiries
For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team: